Antineoplastic combinations with mtor inhibitor, herceptin,...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01)

Patent

CA 2626326

A combination of temsirolimus and herceptin in the treatment of cancer is provided. A combination of temsirolimus and HKI-272 is provided. A combination of herceptin and HKI-272 is also provided. Regimens and kits for treatment of metastatic breast cancer, containing herceptin, temsirolimus and/or HKI-272, optionally in combination with other anti-neoplastic agents, or immune modulators are described.

La présente invention concerne une combinaison de temsirolimus et d'herceptine pour le traitement du cancer. L'invention concerne plus particulièrement une combinaison de temsirolimus et de HKI-272. L'invention concerne également une combinaison d'herceptine et de HKI-272. L'invention concerne enfin des schémas posologiques et des nécessaires pour le traitement du cancer du sein métastatique, à base d'herceptine, de temsirolimus et/ou de HKI-272, éventuellement en association avec d'autres antinéoplasiques ou modulateurs immunitaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antineoplastic combinations with mtor inhibitor, herceptin,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antineoplastic combinations with mtor inhibitor, herceptin,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antineoplastic combinations with mtor inhibitor, herceptin,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2087880

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.